GapScore, Inc.

Measuring the gaps that define cancer vulnerability

Contact Us

About

Measuring the gaps that define cancer vulnerability

GapScore’s diagnostic platform reveals hidden
vulnerabilities in tumor DNA replication to guide targeted, effective cancer treatments.

Learn more

What We Do

“Closing the Diagnostic Gap in Cancer Care”

GapScore is a biotech diagnostics platform that detects single-stranded DNA replication gaps in cancer cells. By measuring these previously overlooked defects in DNA integrity, GapScore can reveal how a tumor is likely to respond to therapies. This new biomarker allows researchers and clinicians to tailor treatment strategies to each patient’s unique tumor profile, improving effectiveness and avoiding unnecessary toxicity.

Contact Us

News

Awarded $400,000 NCI STTR Grant

SEPTEMBER, 2026

Learn more

GapScore Establishes First Laboratory

OCTOBER, 2026

Learn more

Whalen Wins Award at Equalize Startups

JUNE, 2025

Learn more